# Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy

> **NCT01239004** · PHASE4 · COMPLETED · sponsor: **Radiant Research** · enrollment: 140 (actual)

## Conditions studied

- Dyslipidemia
- Hyperlipidemia
- Hyperglycemia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Colesevelam

## Key facts

- **NCT ID:** NCT01239004
- **Lead sponsor:** Radiant Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2012-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239004, "Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01239004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*